RIPK3 and acute kidney injury: Similarly, in both cisplatin- and IRI-AKI, MLKL and RIPK3 deficiency reduces necroptosis, and also the tubular expression of inflammatory cytokines, such as TNFα, that trigger necroptosis (55, 74).